<?xml version="1.0" encoding="UTF-8"?>
<Bundle xmlns="http://hl7.org/fhir">
    <id value="bundlepackageleaflet-xeljanz-5mg" />
    <meta>
        <lastUpdated value="2022-03-04T00:00:00Z" />
        <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi" />
    </meta>
    <identifier>
        <system value="http://ema.europa.eu/fhir/epiDocument" />
        <value value="xeljanz" />
    </identifier>
    <type value="document" />
    <timestamp value="2017-03-22T00:00:00Z" />
    <entry>
        <fullUrl value="Composition/pil1mg" />
        <resource>
            <Composition>
                <id value="pil1mg" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi" />
                </meta>
                <language value="en" />
                <text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">
                        <p>electronic Product Information (ePI) document</p>
                    </div>
                </text>
                <identifier>
                    <system value="http://ema.europa.eu/fhir/epiDocument" />
                    <value value="0d69fdcb-33cf-407f-8209-a6529856ab4f" />
                </identifier>
                <version value="1" />
                <contained>
                    <Binary>
                        <id value="step0" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="step1" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="step2" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="step3" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="step4" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="step5" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="step6" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="step7" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="step8" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="step9" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="step10" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="step11" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <extension url="http://hl7.org/fhir">
                    <valueReference>
                        <reference value="#step0" />
                    </valueReference>
                </extension>
                <extension url="http://hl7.org/fhir">
                    <valueReference>
                        <reference value="#step1" />
                    </valueReference>
                </extension>
                <extension url="http://hl7.org/fhir">
                    <valueReference>
                        <reference value="#step2" />
                    </valueReference>
                </extension>
                <extension url="http://hl7.org/fhir">
                    <valueReference>
                        <reference value="#step3" />
                    </valueReference>
                </extension>
                <extension url="http://hl7.org/fhir">
                    <valueReference>
                        <reference value="#step4" />
                    </valueReference>
                </extension>
                <extension url="http://hl7.org/fhir">
                    <valueReference>
                        <reference value="#step5" />
                    </valueReference>
                </extension>
                <extension url="http://hl7.org/fhir">
                    <valueReference>
                        <reference value="#step6" />
                    </valueReference>
                </extension>
                <extension url="http://hl7.org/fhir">
                    <valueReference>
                        <reference value="#step7" />
                    </valueReference>
                </extension>
                <extension url="http://hl7.org/fhir">
                    <valueReference>
                        <reference value="#step8" />
                    </valueReference>
                </extension>
                <extension url="http://hl7.org/fhir">
                    <valueReference>
                        <reference value="#step9" />
                    </valueReference>
                </extension>
                <extension url="http://hl7.org/fhir">
                    <valueReference>
                        <reference value="#step10" />
                    </valueReference>
                </extension>
                <extension url="http://hl7.org/fhir">
                    <valueReference>
                        <reference value="#step11" />
                    </valueReference>
                </extension>
                <status value="final" />
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/v1/lists/100000155531/terms/" />
                        <code value="100000155538" />
                        <display value="Package Leaflet" />
                    </coding>
                </type>
                <date value="2023-02-17T00:00:00Z" />
                <subject>
                    <reference value="MedicinalProductDefinition/mp1mgml" />
                </subject>
                <author>
                    <reference value="Organization/PfizerEuropeMAEEIG" />
                </author>
                <title value="XELJANZ (tofacitinib) 1 mg/mL oral solution" />
                <section id="80505a60-0d4e-ee11-be6e-000d3aaa06fe">
                    <title value="PACKAGE LEAFLET" />
                    <code>
              <coding>
                <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                <code value="200000029894" />
                <display value="PACKAGE LEAFLET" />
              </coding>
            </code>
                    <text>
                        <status value="generated" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <h1 style="text-align: center;">Package Leaflet: Information for the Patient</h1>
                            <h2 style="text-align: center;">XELJANZ 1 mg/mL oral solution</h2>
                            <h3 style="text-align: center;">tofacitinib</h3>
                            <p>Read all of this leaflet carefully before you start taking this medicine because it
                                contains important information for you.</p>
                            <ul>
                                <li>Keep this leaflet. You may need to read it again.</li>
                                <li>If you have any further questions, ask your doctor or pharmacist.</li>
                                <li>This medicine has been prescribed for you only. Do not pass it on to others. It
                                    may harm them, even if their signs of illness are the same as yours.</li>
                                <li>If you get any side effects, talk to your doctor or pharmacist. This includes
                                    any possible side effects not listed in this leaflet. See section 4.</li>
                            </ul>
                            <p>In addition to this leaflet, your doctor will also give you a Patient Alert Card,
                                which contains important safety information that you need to be aware of before you
                                are given XELJANZ and during treatment with XELJANZ. Keep this Patient Alert Card
                                with you.</p>
                            <h2>What is in this leaflet</h2>
                            <ol>
                                <li>What XELJANZ is and what it is used for</li>
                                <li>What you need to know before you take XELJANZ</li>
                                <li>How to take XELJANZ</li>
                                <li>Possible side effects</li>
                                <li>How to store XELJANZ</li>
                                <li>Contents of the pack and other information</li>
                                <li>Instructions for Use of XELJANZ oral solution</li>
                            </ol>
                        </div>
                    </text>
                    <section id="84505a60-0d4e-ee11-be6e-000d3aaa06fe">
                        <title value="1. What ProductX CompanyY is and what it is used for" />
                        <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                  <code value="200000029895" />
                  <display value="1. What X is and what it is used for" />
                </coding>
              </code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <h2>1. What XELJANZ is and what it is used for</h2>
                                <p>XELJANZ 1 mg/mL oral solution is a medicine that contains the active substance
                                    tofacitinib. XELJANZ 1 mg/mL oral solution is used for the treatment of active
                                    polyarticular juvenile idiopathic arthritis, a long-term disease that mainly causes
                                    pain and swelling of your joints, in patients 2 years of age and older.</p>
                                <p>XELJANZ 1 mg/mL oral solution is also used for the treatment of juvenile psoriatic
                                    arthritis, a condition that is an inflammatory disease of the joints often
                                    accompanied by psoriasis, in patients 2 years of age and older.</p>
                                <p>XELJANZ 1 mg/mL oral solution can be used together with methotrexate when previous
                                    treatment for polyarticular juvenile idiopathic arthritis or juvenile psoriatic
                                    arthritis was not sufficient or was not well tolerated. XELJANZ 1 mg/mL oral
                                    solution can also be taken on its own in those cases where methotrexate treatment is
                                    not tolerated or treatment with methotrexate is not advised.</p>
                            </div>
                        </text>
                    </section>
                    <section id="8b505a60-0d4e-ee11-be6e-000d3aaa06fe">
                        <title value="2. What you need to know before you take ProductX CompanyY" />
                        <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                  <code value="200000029896" />
                  <display value="2. What you need to know before you &lt;take&gt; &lt;use&gt; X" />
                </coding>
              </code>
                        <section id="92505a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="Do not take ProductX CompanyY" />
                            <code>
                  <coding>
                    <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                    <code value="200000029897" />
                    <display value="Do not &lt;take&gt; &lt;use&gt; X" />
                  </coding>
                </code>
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <ul>
                                        <li>if you are allergic to tofacitinib or any of the other ingredients of this
                                            medicine (listed in section 6)</li>
                                        <li>if you have a severe infection such as bloodstream infection or active
                                            tuberculosis</li>
                                        <li>if you have been informed that you have severe liver problems, including
                                            cirrhosis (scarring of the liver)</li>
                                        <li>if you are pregnant or breast-feeding</li>
                                    </ul>
                                    <p>If you are not sure regarding any of the information provided above, please
                                        contact your doctor.</p>
                                </div>
                            </text>
                        </section>
                        <section id="99505a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="Warnings and precautions" />
                            <code>
                  <coding>
                    <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                    <code value="200000029898" />
                    <display value="Warnings and precautions" />
                  </coding>
                </code>
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <p>Talk to your doctor or pharmacist before taking XELJANZ:</p>
                                    <ul>
                                        <li>if you think you have an infection or have symptoms of an infection such as
                                            fever, sweating, chills, muscle aches, cough, shortness of breath, new
                                            phlegm or change in phlegm, weight loss, warm or red or painful skin or
                                            sores on your body, difficulty or pain when swallowing, diarrhoea or stomach
                                            pain, burning when you urinate or urinating more often than normal, feeling
                                            very tired</li>
                                        <li>if you have any condition that increases your chance of infection (e.g.,
                                            diabetes, HIV/AIDS, or a weak immune system)</li>
                                        <li>if you have any kind of infection, are being treated for any infection, or
                                            if you have infections that keep coming back. Tell your doctor immediately
                                            if you feel unwell. XELJANZ can reduce your body’s ability to respond to
                                            infections and may make an existing infection worse or increase the chance
                                            of getting a new infection</li>
                                        <li>if you have or have a history of tuberculosis or have been in close contact
                                            with someone with tuberculosis. Your doctor will test you for tuberculosis
                                            before starting XELJANZ and may retest during treatment</li>
                                        <li>if you have any chronic lung disease</li>
                                        <li>if you have liver problems</li>
                                        <li>if you have or had hepatitis B or hepatitis C (viruses that affect the
                                            liver). The virus may become active while you are taking XELJANZ. Your
                                            doctor may do blood tests for hepatitis before you start treatment with
                                            XELJANZ and while you are taking XELJANZ</li>
                                        <li>if you have ever had any type of cancer, and also if you are a current or
                                            past smoker. XELJANZ may increase your risk of certain cancers. White blood
                                            cell cancer, lung cancer and other cancers (such as breast, skin, prostate
                                            and pancreatic) have been reported in patients treated with XELJANZ. If you
                                            develop cancer while taking XELJANZ your doctor will review whether to stop
                                            XELJANZ treatment.</li>
                                        <li>if you are at known risk of fractures, e.g., if you are 65 years of age and
                                            older, you are a female, or take corticosteroids (e.g., prednisone). Cases
                                            of non-melanoma skin cancer have been observed in patients taking XELJANZ.
                                            Your doctor may recommend that you have regular skin examinations while
                                            taking XELJANZ. If new skin lesions appear during or after therapy or if
                                            existing lesions change appearance, tell your doctor.</li>
                                        <li>if you have had diverticulitis (a type of inflammation of the large
                                            intestine) or ulcers in stomach or intestines (see section 4)</li>
                                        <li>if you have kidney problems</li>
                                        <li>if you are planning to get vaccinated, tell your doctor. Certain types of
                                            vaccines should not be given when taking XELJANZ. Before you start XELJANZ,
                                            you should be up to date with all recommended vaccinations. Your doctor will
                                            decide whether you need to have herpes zoster vaccination.</li>
                                        <li>if you have heart problems, high blood pressure, high cholesterol, and also
                                            if you are a current or past smoker</li>
                                    </ul>
                                    <p>There have been reports of patients treated with XELJANZ who have developed blood
                                        clots in the lungs or veins. Your doctor will evaluate your risk to develop
                                        blood clots in the lungs or veins and determine if XELJANZ is appropriate for
                                        you. If you have already had problems on developing blood clots in lungs and
                                        veins or have an increased risk for developing this (for example: if you are
                                        seriously overweight, if you have cancer, heart problems, diabetes, experienced
                                        a heart attack (within previous 3 months), recent major surgery, if you use
                                        hormonal contraceptives/hormonal replacement therapy, if a coagulation defect is
                                        identified in you or your close relatives), or if you smoke currently or in the
                                        past, your doctor may decide that XELJANZ is not suitable for you.</p>
                                    <p>Talk to your doctor straight away:</p>
                                    <ul>
                                        <li>if you develop sudden shortness of breath or difficulty breathing, chest
                                            pain or pain in upper back, swelling of the leg or arm, leg pain or
                                            tenderness, or redness or discoloration in the leg or arm while taking
                                            XELJANZ, as these may be signs of a clot in the lungs or veins</li>
                                        <li>if you experience acute changes to your eyesight (blurry vision, partial or
                                            complete loss of vision), as this may be a sign of blood clots in the eyes.
                                        </li>
                                        <li>if you develop signs and symptoms of a heart attack including severe chest
                                            pain or tightness (that may spread to arms, jaw, neck, back), shortness of
                                            breath, cold sweat, light headedness or sudden dizziness. There have been
                                            reports of patients treated with XELJANZ who have had a heart problem,
                                            including heart attack. Your doctor will evaluate your risk to develop a
                                            heart problem and determine if XELJANZ is appropriate for you.</li>
                                        <li>if you, your partner or your caregiver notice new onset or worsening of
                                            neurological symptoms including general muscle weakness, disturbance of
                                            vision, changes in thinking, memory and orientation leading to confusion and
                                            personality changes contact your doctor immediately because these may be
                                            symptoms of a very rare, serious brain infection called progressive
                                            multifocal leukoencephalopathy (PML).</li>
                                    </ul>
                                    <u>Additional monitoring tests</u>
                                    <p>Your doctor should perform blood tests before you start taking XELJANZ, and after
                                        4 to 8 weeks of treatment and then every 3 months, to determine if you have a
                                        low white blood cell (neutrophil or lymphocyte) count, or a low red blood cell
                                        count (anaemia).</p>
                                    <p>You should not receive XELJANZ if your white blood cell (neutrophil or
                                        lymphocyte) count or red blood cell count is too low. If needed, your doctor may
                                        interrupt your XELJANZ treatment to reduce the risk of infection (white blood
                                        cell counts) or anaemia (red blood cell counts).</p>
                                    <p>Your doctor may also perform other tests, for example to check your blood
                                        cholesterol levels or monitor the health of your liver. Your doctor should test
                                        your cholesterol levels 8 weeks after you start receiving XELJANZ. Your doctor
                                        should perform liver tests periodically.</p>
                                    <b>Elderly</b>
                                    <p>The safety and efficacy of tofacitinib 1 mg/mL oral solution has not been
                                        established in the elderly.</p>
                                    <b>Asian patients</b>
                                    <p>There is a higher rate of shingles in Japanese and Korean patients. Tell your
                                        doctor if you notice any painful blisters on your skin.</p>
                                    <p>You may also be at higher risk of certain lung problems. Tell your doctor if you
                                        notice any breathing difficulties.</p>
                                    <b>Children and adolescents</b>
                                    <p>This medicine should not be given to patients less than 2 years of age.</p>
                                    <p>This medicine contains propylene glycol and should be used with caution in
                                        patients 2 years of age and older and only if advised by the doctor (see
                                        "XELJANZ contains propylene glycol").</p>
                                </div>
                            </text>
                        </section>
                        <section id="a6505a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="Other medicines and XELJANZ" />
                            <code>
                  <coding>
                    <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                    <code value="200000029900" />
                    <display value="Other medicines and X" />
                  </coding>
                </code>
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <p><strong>Tell your doctor or pharmacist if you are taking, have recently taken or
                                            might take any other medicines.</strong></p>
                                    <p>Tell your doctor if you have diabetes or are taking medicines to treat diabetes.
                                        Your doctor may decide if you need less anti-diabetic medicine while taking
                                        tofacitinib.</p>
                                    <p>Some medicines should not be taken with XELJANZ. If taken with XELJANZ, they
                                        could alter the level of XELJANZ in your body, and the dose of XELJANZ may
                                        require adjustment. You should tell your doctor if you are using medicines that
                                        contain any of the following active substances:</p>
                                    <ul>
                                        <li>antibiotics such as rifampicin, used to treat bacterial infections</li>
                                        <li>fluconazole, ketoconazole, used to treat fungal infections</li>
                                    </ul>
                                    <p>XELJANZ is not recommended for use with medicines that depress the immune system,
                                        including so-called targeted biologic (antibody) therapies, such as those that
                                        inhibit tumour necrosis factor, interleukin-17, interleukin-12/interleukin-23,
                                        anti-integrins, and strong chemical immunosuppressants including azathioprine,
                                        mercaptopurine, ciclosporin, and tacrolimus. Taking XELJANZ with these medicines
                                        may increase your risk of side effects including infection.</p>
                                    <p>Serious infections and fractures may happen more often in people who also take
                                        corticosteroids (e.g., prednisone).</p>
                                    <p><strong>Pregnancy and breast-feeding</strong></p>
                                    <p>If you are a woman of childbearing age, you should use effective birth control
                                        during treatment with XELJANZ and for at least 4 weeks after the last dose.</p>
                                    <p>If you are pregnant or breast-feeding, think you may be pregnant or are planning
                                        to have a baby, ask your doctor for advice before taking this medicine. XELJANZ
                                        must not be used during pregnancy. Tell your doctor right away if you become
                                        pregnant while taking XELJANZ.</p>
                                    <p>If you are taking XELJANZ and breast-feeding, you must stop breast-feeding until
                                        you talk to your doctor about stopping treatment with XELJANZ.</p>
                                    <p><strong>Driving and using machines</strong></p>
                                    <p>XELJANZ has no or limited effect on your ability to drive or use machines.</p>
                                    <p><strong>XELJANZ contains propylene glycol</strong></p>
                                    <p>This medicine contains 2.39 mg propylene glycol in each mL of oral solution.</p>
                                    <p><strong>XELJANZ contains sodium benzoate</strong></p>
                                    <p>This medicine contains 0.9 mg sodium benzoate in each mL of oral solution.</p>
                                    <p><strong>XELJANZ contains sodium</strong></p>
                                    <p>This medicine contains less than 1 mmol sodium (23 mg) per mL, that is to say
                                        essentially ‘sodium-free’.</p>
                                </div>
                            </text>
                        </section>
                        <section id="b4505a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="Pregnancy, breast-feeding and fertility" />
                            <code>
                  <coding>
                    <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                    <code value="200000029902" />
                    <display value="Pregnancy &lt;and&gt; &lt;,&gt; breast-feeding &lt;and fertility&gt;" />
                  </coding>
                </code>
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">

                                </div>
                            </text>
                        </section>
                        <section id="bb505a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="Driving and using machines" />
                            <code>
                  <coding>
                    <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                    <code value="200000029903" />
                    <display value="Driving and using machines" />
                  </coding>
                </code>
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">

                                </div>
                            </text>
                        </section>
                    </section>
                    <section id="c5505a60-0d4e-ee11-be6e-000d3aaa06fe">
                        <title value="3. How to take XELJANZ" />
                        <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                  <code value="200000029905" />
                  <display value="3. How to &lt;take&gt; &lt;use&gt; X" />
                </coding>
              </code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <p>This medicine is provided to you and supervised by a specialised doctor who knows how
                                    to treat your condition.</p>
                                <p>Always take this medicine exactly as your doctor has told you, the recommended dose
                                    should not be exceeded. Check with your doctor or pharmacist if you are not sure.
                                </p>
                                <p>The recommended dose in patients 2 years of age and older is based upon the following
                                    weight categories (see Table 1).</p>
                                <p><strong>Table 1. XELJANZ dose for patients with polyarticular juvenile idiopathic
                                        arthritis and juvenile PsA two years of age and older:</strong></p>
                                <table border="1">
                                    <tr>
                                        <th>Body weight (kg)</th>
                                        <th>Dose regimen</th>
                                    </tr>
                                    <tr>
                                        <td>10 - &lt;20</td>
                                        <td>3.2 mg (3.2 mL of oral solution) twice daily</td>
                                    </tr>
                                    <tr>
                                        <td>20 - &lt;40</td>
                                        <td>4 mg (4 mL of oral solution) twice daily</td>
                                    </tr>
                                    <tr>
                                        <td>≥ 40</td>
                                        <td>5 mg (5 mL of oral solution or 5 mg film-coated tablet) twice daily</td>
                                    </tr>
                                </table>
                                <p>Your doctor may reduce the dose if you have liver or kidney problems or if you are
                                    prescribed certain other medicines. Your doctor may also stop treatment temporarily
                                    or permanently if blood tests show low white blood cell or red blood cell counts.
                                </p>
                                <p>If you suffer from polyarticular juvenile idiopathic arthritis or juvenile psoriatic
                                    arthritis, your doctor may switch you from XELJANZ 5 mL oral solution twice daily to
                                    XELJANZ 5 mg film-coated tablets twice daily. XELJANZ is for oral use. You can take
                                    XELJANZ with or without food.</p>
                                <p>Try to take XELJANZ at the same time every day (once in the morning and once in the
                                    evening).</p>
                                <p><strong>If you take more XELJANZ than you should</strong></p>
                                <p>If you take more XELJANZ 1 mg/mL oral solution than you should, immediately tell your
                                    doctor or pharmacist.</p>
                                <p><strong>If you forget to take XELJANZ</strong></p>
                                <p>Do not take a double dose to make up for a forgotten dose. Take your next dose at the
                                    usual time and continue as before.</p>
                                <p><strong>If you stop taking XELJANZ</strong></p>
                                <p>You should not stop taking XELJANZ without discussing this with your doctor.</p>
                                <p>If you have any further questions on the use of this medicine, ask your doctor or
                                    pharmacist.</p>
                            </div>
                        </text>
                        <section id="07515a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="How much ProductX CompanyY to take" />
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">

                                </div>
                            </text>
                        </section>
                        <section id="0d515a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="Use in children and adolescents" />
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">

                                </div>
                            </text>
                        </section>
                        <section id="0f515a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="When and how to take ProductX CompanyY" />
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">

                                </div>
                            </text>
                        </section>
                        <section id="ce9c5266-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="How long to take ProductX CompanyY" />
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">

                                </div>
                            </text>
                        </section>
                        <section id="d49c5266-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="If you take more ProductX CompanyY than you should" />
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">

                                </div>
                            </text>
                        </section>
                        <section id="d79c5266-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="If you forget to take ProductX CompanyY" />
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">

                                </div>
                            </text>
                        </section>
                    </section>
                    <section id="dc505a60-0d4e-ee11-be6e-000d3aaa06fe">
                        <title value="4. Possible side effects" />
                        <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                  <code value="200000029910" />
                  <display value="4. Possible side effects" />
                </coding>
              </code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <p>Like all medicines, this medicine can cause side effects, although not everybody gets
                                    them. Some may be serious and need medical attention.</p>
                                <p>Side effects in patients with polyarticular juvenile idiopathic arthritis and
                                    juvenile psoriatic arthritis were consistent with those seen in adult rheumatoid
                                    arthritis patients with the exception of some infections (influenza, pharyngitis,
                                    sinusitis, viral infection) and gastrointestinal or general disorders (abdominal
                                    pain, nausea, vomiting, fever, headache, cough), which were more common in juvenile
                                    idiopathic arthritis paediatric population.</p>
                                <p><strong>Possible serious side effects</strong></p>
                                <p>In rare cases, infection may be life-threatening. Lung cancer, white blood cell
                                    cancer and heart attack have also been reported.</p>
                                <p>If you notice any of the following serious side effects you need to tell a doctor
                                    straight away.</p>
                                <p><strong>Signs of serious infections (common) include</strong></p>
                                <ul>
                                    <li>fever and chills</li>
                                    <li>cough</li>
                                    <li>skin blisters</li>
                                    <li>stomach ache</li>
                                    <li>persistent headaches</li>
                                </ul>
                                <p><strong>Signs of ulcers or holes (perforations) in your stomach (uncommon)
                                        include</strong></p>
                                <ul>
                                    <li>fever</li>
                                    <li>stomach or abdominal pain</li>
                                    <li>blood in the stool</li>
                                    <li>unexplained changes in bowel habits</li>
                                </ul>
                                <p>Holes in stomach or intestines happen most often in people who also take nonsteroidal
                                    anti-inflammatory drugs or corticosteroids (e.g., prednisone).</p>
                                <p><strong>Signs of allergic reactions (unknown) include</strong></p>
                                <ul>
                                    <li>chest tightness</li>
                                    <li>wheezing</li>
                                    <li>severe dizziness or light-headedness</li>
                                    <li>swelling of the lips, tongue or throat</li>
                                    <li>hives (itching or skin rash)</li>
                                </ul>
                                <p><strong>Signs of blood clots in lungs or veins or eyes (uncommon: venous
                                        thromboembolism) include</strong></p>
                                <ul>
                                    <li>sudden shortness of breath or difficulty breathing</li>
                                    <li>chest pain or pain in upper back</li>
                                    <li>swelling of the leg or arm</li>
                                    <li>leg pain or tenderness</li>
                                    <li>redness or discoloration in the leg or arm</li>
                                    <li>acute changes in eyesight</li>
                                </ul>
                                <p><strong>Signs of a heart attack (uncommon) include</strong></p>
                                <ul>
                                    <li>severe chest pain or tightness (that may spread to arms, jaw, neck, back)</li>
                                    <li>shortness of breath</li>
                                    <li>cold sweat</li>
                                    <li>light headedness or sudden dizziness</li>
                                </ul>
                                <p>Other side effects which have been observed with XELJANZ are listed below.</p>
                                <p><strong>Common (may affect up to 1 in 10 people):</strong> lung infection (pneumonia
                                    and bronchitis), shingles (herpes zoster), infections of nose, throat or the
                                    windpipe (nasopharyngitis), influenza, sinusitis, urinary bladder infection
                                    (cystitis), sore throat (pharyngitis), increased muscle enzymes in the blood (sign
                                    of muscle problems), stomach (belly) pain (which may be from inflammation of the
                                    stomach lining), vomiting, diarrhoea, feeling sick (nausea), indigestion, low white
                                    blood cell counts, low red blood cell count (anaemia), swelling of the feet and
                                    hands, headache, high blood pressure (hypertension), cough, rash, acne.</p>
                                <p><strong>Uncommon (may affect up to 1 in 100 people):</strong> lung cancer,
                                    tuberculosis, kidney infection, skin infection, herpes simplex or cold sores (oral
                                    herpes), blood creatinine increased (a possible sign of kidney problems), increased
                                    cholesterol (including increased LDL), fever, fatigue (tiredness), weight gain,
                                    dehydration, muscle strain, tendonitis, joint swelling, joint sprain, abnormal
                                    sensations, poor sleep, sinus congestion, shortness of breath or difficulty
                                    breathing, skin redness, itching, fatty liver, painful inflammation of small pockets
                                    in the lining of your intestine (diverticulitis), viral infections, viral infections
                                    affecting the gut, some types of skin cancers (non-melanoma-types).</p>
                                <p><strong>Rare (may affect up to 1 in 1,000 people):</strong> blood infection (sepsis),
                                    lymphoma (white blood cell cancer), disseminated tuberculosis involving bones and
                                    other organs, other unusual infections, joint infections, increased liver enzymes in
                                    the blood (sign of liver problems), pain in the muscles and joints.</p>
                                <p><strong>Very rare (may affect up to 1 in 10,000 people):</strong> tuberculosis
                                    involving the brain and spinal cord, meningitis, infection of the soft tissue and
                                    fascia.</p>
                                <p>In general, fewer side effects were seen when XELJANZ was used alone than in
                                    combination with methotrexate in rheumatoid arthritis.</p>
                                <p><strong>Reporting of side effects</strong></p>
                                <p>If you get any side effects, talk to your doctor or pharmacist. This includes any
                                    possible side effects not listed in this leaflet. You can also report side effects
                                    directly via the national reporting system listed in Appendix V. By reporting side
                                    effects you can help provide more information on the safety of this medicine.</p>
                            </div>
                        </text>
                        <section id="e5505a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="Reporting of side effects" />
                            <code>
                  <coding>
                    <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                    <code value="200000029912" />
                    <display value="Reporting of side effects" />
                  </coding>
                </code>
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">

                                </div>
                            </text>
                        </section>
                    </section>
                    <section id="e9505a60-0d4e-ee11-be6e-000d3aaa06fe">
                        <title value="5. How to store XELJANZ" />
                        <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                  <code value="200000029913" />
                  <display value="5. How to store X" />
                </coding>
              </code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <p>Keep this medicine out of the sight and reach of children.</p>
                                <p>Do not use this medicine after the expiry date which is stated on the carton or
                                    bottle. The expiry date refers to the last day of that month.</p>
                                <p>This medicine does not require any special temperature storage conditions.</p>
                                <p>Store in the original bottle and package in order to protect from light.</p>
                                <p>Discard after 60 days of first opening.</p>
                                <p>Do not use this medicine if you notice the solution shows visible signs of
                                    deterioration.</p>
                                <p>Do not throw away any medicines via wastewater or household waste. Ask your
                                    pharmacist how to throw away medicines you no longer use. These measures will help
                                    protect the environment.</p>
                            </div>
                        </text>
                    </section>
                    <section id="eb505a60-0d4e-ee11-be6e-000d3aaa06fe">
                        <title value="6. Contents of the pack and other information" />
                        <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                  <code value="200000029914" />
                  <display value="6. Contents of the pack and other information" />
                </coding>
              </code>
                        <section id="f0505a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="What XELJANZ contains" />
                            <code>
                  <coding>
                    <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                    <code value="200000029915" />
                    <display value="What X contains" />
                  </coding>
                </code>
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <ul>
                                        <li>The active substance is tofacitinib.</li>
                                        <li>Each 1 mL contains 1 mg of tofacitinib (as tofacitinib citrate).</li>
                                        <li>The other ingredients are grape flavour [containing propylene glycol (E1520)
                                            (see section 2 “XELJANZ contains propylene glycol”), glycerin (E422), and
                                            natural flavours], hydrochloric acid, lactic acid (E270), purified water,
                                            sodium benzoate (E211) (see section 2 “XELJANZ contains sodium benzoate” and
                                            “XELJANZ contains sodium”), sucralose (E955), and xylitol (E967).</li>
                                    </ul>
                                    <p><strong>What XELJANZ looks like and contents of the pack</strong></p>
                                    <p>XELJANZ 1 mg/mL oral solution is a clear, colourless solution.</p>
                                    <p>The 1 mg/mL oral solution is provided in white coloured HDPE 250 mL bottles
                                        containing 240 mL of solution. Each pack contains one HDPE bottle, one press-in
                                        bottle adapter, and one oral dosing syringe with 3.2 mL, 4 mL, and 5 mL
                                        graduations.</p>
                                </div>
                            </text>
                        </section>
                        <section id="f3505a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="What XELJANZ looks like and contents of the pack" />
                            <code>
                  <coding>
                    <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                    <code value="200000029916" />
                    <display value="What X looks like and contents of the pack" />
                  </coding>
                </code>
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <p>XELJANZ 1 mg/mL oral solution is a clear, colourless solution.</p>
                                    <p>The 1 mg/mL oral solution is provided in white coloured HDPE 250 mL bottles
                                        containing 240 mL of solution. Each pack contains one HDPE bottle, one press-in
                                        bottle adapter, and one oral dosing syringe with 3.2 mL, 4 mL, and 5 mL
                                        graduations.</p>
                                </div>
                            </text>
                        </section>
                        <section id="f7505a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="Marketing Authorisation Holder" />
                            <code>
                  <coding>
                    <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                    <code value="200000029917" />
                    <display value="Marketing Authorisation Holder and Manufacturer" />
                  </coding>
                </code>
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <p><strong>Marketing Authorisation Holder</strong></p>
                                    <p>Pfizer Europe MA EEIG</p>
                                    <p>
                                        Boulevard de la Plaine 17</p>
                                    <p>
                                        1050 Bruxelles</p>
                                    <p>
                                        Belgium</p>
                                    <p><strong>Manufacturer</strong></p>
                                    <p>Pfizer Service Company BV</p>
                                    <p>
                                        Hoge Wei 10</p>
                                    <p>
                                        1930 Zaventem</p>
                                    <p>
                                        Belgium</p>
                                </div>
                            </text>
                        </section>
                        <section id="fb505a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="This leaflet was last revised in" />
                            <code>
                  <coding>
                    <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                    <code value="200000029919" />
                    <display value="This leaflet was last revised in &lt;{MM/YYYY}&gt;&lt;{month YYYY}&gt;." />
                  </coding>
                </code>
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">&#160;</div>
                            </text>
                        </section>
                        <section id="01515a60-0d4e-ee11-be6e-000d3aaa06fe">
                            <title value="Other sources of information" />
                            <code>
                  <coding>
                    <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                    <code value="200000029920" />
                    <display value="Other sources of information" />
                  </coding>
                </code>
                            <text>
                                <status value="generated" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <p>For any information about this medicine, please contact the local representative
                                        of the Marketing Authorisation Holder.</p>
                                </div>
                            </text>
                        </section>
                    </section>
                    <section id="f3505a60-0d4e-ee11-be6e-000d3aaa06fe">
                        <title value="7. Instructions for Use of XELJANZ oral solution" />
                        <code>
              <coding>
                <system value="https://spor.ema.europa.eu/v1/lists/200000029659/terms/" />
                <code value="200000029916" />
                <display value="7. Instructions for Use of XELJANZ oral solution" />
              </coding>
            </code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <p><strong>Read this Instructions for Use before you start taking XELJANZ oral solution.
                                        There may be new information.</strong></p>
                                <p><strong>Important information about measuring XELJANZ oral solution</strong></p>
                                <p>Always use the oral dosing syringe that comes with your XELJANZ oral solution to
                                    measure and administer your prescribed dose. Ask your healthcare provider or
                                    pharmacist to show you how to measure your prescribed dose if you are not sure.</p>
                                <p><strong>How should I store XELJANZ?</strong></p>
                                <p>Keep this medicine out of the sight and reach of children.</p>
                                <p>Discard remaining XELJANZ oral solution after 60 days.</p>
                                <p>To help you remember when to dispose of your XELJANZ bottle you can write the date of
                                    first use on the carton and below:</p>
                                <p>Date of first use ____ / ____ / ____.</p>


                                <p><strong>Each carton of XELJANZ oral solution contains</strong></p>
                                <ul>
                                    <li>1 press-in bottle adapter</li>
                                    <li>1 bottle of XELJANZ oral solution</li>
                                    <li>1 oral dosing syringe</li>
                                </ul>
                                <p><img src="#step0" alt="Contents of the carton" /></p>

                                <p><strong>Before each use:</strong></p>
                                <p><strong>Wash your hands with soap and water and place the items from the carton on a
                                        clean
                                        flat surface.</strong>
                                </p>
                                <p><strong>Step 1. Remove bottle from carton</strong></p>
                                <p>
                                    <img src="#step1" alt="Step 1. Remove bottle from carton" />
                                </p>
                                <p>Remove the bottle of XELJANZ oral solution from the carton.
                                </p>
                                <p><strong>Step 2. Open bottle</strong></p>
                                <p>
                                    <img src="#step2" alt="Step 2. Open bottle" />
                                </p>
                                <p>Open the bottle. Remove the seal off the top of the bottle (first time only).</p>
                                <p>
                                    Do not throw away the child-resistant cap.</p>
                                <p>
                                    Note: Bottle does not need to be shaken before use.
                                </p>

                                <p><strong>Step 3. Insert press-in bottle adapter</strong></p>
                                <p>
                                    <img src="#step3" alt="Step 3. Insert press-in bottle adapter" />

                                </p>
                                <p>Remove the press-in bottle adapter and oral dosing syringe from the plastic
                                    overwrap. With the bottle on a flat surface, push the ribbed end of the press-in
                                    bottle adapter with your thumbs all the way into the neck of the bottle while
                                    holding the bottle firmly.</p>
                                <p>
                                    Note: Do not remove the press-in bottle adapter from the bottle after it is
                                    inserted.
                                </p>
                                <p><strong>Step 4. Remove air from oral dosing syringe</strong></p>
                                <p><img src="#step4" alt="Step 4. Remove air from oral dosing syringe" />
                                </p>
                                <p>Push the oral dosing syringe plunger fully to the tip of the syringe barrel to
                                    remove excess air.</p>

                                <p><strong>Step 5. Insert the oral dosing syringe</strong></p>
                                <p>
                                    <img src="#step5" alt="Step 5. Insert the oral dosing syringe" />

                                </p>
                                <p>Insert the oral dosing syringe into the upright bottle through the opening of the
                                    press-in bottle adapter until it is firmly in place.
                                </p>

                                <p><strong>Step 6. Withdraw dose from bottle</strong></p>
                                <p>
                                    <img src="#step6" alt=" oral dosing syringe" />

                                </p>
                                <p>With the oral dosing syringe in place, turn the bottle upside down. Pull back the
                                    plunger.</p>
                                <p>
                                    If you see air bubbles in the oral dosing syringe, fully push the plunger in to
                                    empty the oral solution back into the bottle. Then withdraw your prescribed dose of
                                    oral solution.
                                </p>

                                <p><strong>Step 7. Remove oral dosing syringe</strong></p>
                                <p>
                                    <img src="#step7" alt="Step 7. Remove oral dosing syringe" />

                                </p>
                                <p>Turn the bottle upright and place the bottle on a flat surface. Remove the
                                    oral
                                    dosing syringe from the bottle adapter and bottle by pulling straight up on
                                    the oral
                                    dosing syringe barrel.
                                </p>

                                <p><strong>Step 8. Checking dose withdrawn</strong></p>
                                <p>
                                    <img src="#step8" alt="Step 8. Checking dose withdrawn" />

                                </p>
                                <p>Check that the correct dose was drawn up into the oral dosing syringe.</p>
                                <p>
                                    If the dose is not correct, insert the oral dosing syringe tip firmly into
                                    the
                                    bottle adapter. Fully push in the plunger so that the oral solution flows
                                    back into
                                    the bottle. Repeat Steps 6 and 7.
                                </p>

                                <p><strong>Step 9. Take the dose of XELJANZ</strong></p>
                                <p>
                                    <img src="#step9" alt="Step 9. Take the dose of XELJANZ" />
                                    Place the tip of the oral dosing syringe into the inside of the patient’s
                                    cheek.
                                </p>
                                <p>
                                    Slowly push the plunger all the way down to give all the medicine in the
                                    oral dosing
                                    syringe. Make sure the patient has time to swallow the medicine.</p>
                                <p>176
                                </p>

                                <p><strong>Step 10. Close the bottle</strong></p>
                                <p>
                                    <img src="#step10" alt="Step 10. Close the bottle" />

                                </p>
                                <p>Close the bottle tightly by turning the child-resistant cap clockwise,
                                    leaving the
                                    press-in bottle adapter in place.</p>
                                <p>
                                    Place the bottle back into the carton and close the carton to protect
                                    XELJANZ oral
                                    solution from light.
                                </p>

                                <p><strong>Step 11. Clean oral dosing syringe</strong></p>
                                <p>
                                    <img src="#step11" alt="Step 11. Clean oral dosing syringe" />

                                </p>
                                <p>Remove the plunger from the barrel by pulling the plunger and the barrel
                                    away from
                                    each other.</p>
                                <p>
                                    Rinse both with water after each use.</p>
                                <p>
                                    Allow to air dry; then put the oral dosing syringe back together with oral
                                    solution
                                    in the carton.</p>
                                <p>
                                    Store the oral dosing syringe with the XELJANZ oral solution.</p>
                                <p>
                                    Do not throw away the oral dosing syringe.
                                </p>
                            </div>
                        </text>
                    </section>
                </section>
            </Composition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/tofacitinib1mgml" />
        <resource>
            <Ingredient>
                <id value="tofacitinib1mgml" />
                <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                    <value value="87LA6FU830" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/mid1mgml" />
                </for>
                <role>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000072072" />
                        <display value="Active" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                <code value="87LA6FU830" />
                <display value="TOFACITINIB" />
              </coding>
            </concept>
          </code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="1" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" />
                                <code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" />
                                <code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/WINEGRAPE" />
        <resource>
            <Ingredient>
                <id value="WINEGRAPE" />
                <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                    <value value="3GOV20705G" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/mid1mgml" />
                </for>
                <role>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000072082" />
                        <display value="Excipient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                <code value="3GOV20705G" />
                <display value="WINE GRAPE" />
              </coding>
            </concept>
          </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/HYDROCHLORICACID" />
        <resource>
            <Ingredient>
                <id value="HYDROCHLORICACID" />
                <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                    <value value="QTT17582CB" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/mid1mgml" />
                </for>
                <role>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000072082" />
                        <display value="Excipient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                <code value="QTT17582CB" />
                <display value="HYDROCHLORIC ACID" />
              </coding>
            </concept>
          </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/LACTICACIDUNSPECIFIEDFORM" />
        <resource>
            <Ingredient>
                <id value="LACTICACIDUNSPECIFIEDFORM" />
                <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                    <value value="33X04XA5AT" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/mid1mgml" />
                </for>
                <role>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000072082" />
                        <display value="Excipient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                <code value="33X04XA5AT" />
                <display value="LACTIC ACID, UNSPECIFIED FORM" />
              </coding>
            </concept>
          </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/WATER" />
        <resource>
            <Ingredient>
                <id value="WATER" />
                <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
                </meta>

                <identifier>
                    <use value="official" />
                    <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                    <value value="059QF0KO0R" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/mid1mgml" />
                </for>
                <role>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000072082" />
                        <display value="Excipient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                <code value="059QF0KO0R" />
                <display value="WATER" />
              </coding>
            </concept>
          </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/SODIUMBENZOATE" />
        <resource>
            <Ingredient>
                <id value="SODIUMBENZOATE" />
                <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                    <value value="OJ245FE5EU" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/mid1mgml" />
                </for>
                <role>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000072082" />
                        <display value="Excipient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                <code value="OJ245FE5EU" />
                <display value="SODIUM BENZOATE" />
              </coding>
            </concept>
          </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/SUCRALOSE" />
        <resource>
            <Ingredient>
                <id value="SUCRALOSE" />
                <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                    <value value="96K6UQ3ZD4" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/mid1mgml" />
                </for>
                <role>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000072082" />
                        <display value="Excipient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                <code value="96K6UQ3ZD4" />
                <display value="SUCRALOSE" />
              </coding>
            </concept>
          </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/XYLITOL " />
        <resource>
            <Ingredient>
                <id value="XYLITOL " />
                <meta>
                <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                    <value value="VCQ006KQ1E" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/mid1mg" />
                </for>
                <role>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000072082" />
                        <display value="Excipient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta" />
                <code value="VCQ006KQ1E" />
                <display value="XYLITOL" />
              </coding>
            </concept>
          </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="SubstanceDefinition/substancetofacitinib" />
        <resource>
            <SubstanceDefinition>
                <id value="substancetofacitinib" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/" />
                    <value value="87LA6FU830" />
                </identifier>
                <version value="1" />
                <status>
                    <coding>
                        <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/" />
                        <code value="1" />
                        <display value="Validated (UNII)" />
                    </coding>
                </status>
                <molecularWeight>
                    <type>
                        <text value="exact" />
                    </type>
                    <amount>
                        <value value="312.37" />
                    </amount>
                </molecularWeight>
                <structure>
                    <molecularFormula value="C16H20N6O" />
                </structure>
                <name>
                    <name
                        value="1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)-" />
                    <type>
                        <coding>
                            <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/" />
                            <code value="x" />
                            <display value="Chemical Name" />
                        </coding>
                    </type>
                </name>
            </SubstanceDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ManufacturedItemDefinition/mid1mgml" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="mid1mgml" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="http://ema.europa.eu/fhir/epiDocument" />
                    <value value="99b900c6-4776-4cde-8125-4f6de8e98b98" />
                </identifier>
                <status value="active" />
                <manufacturedDoseForm>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi/" />
                        <code value="100000073646" />
                        <display value="Oral solution" />
                    </coding>
                </manufacturedDoseForm>
                <unitOfPresentation>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000002120" />
                        <display value="Tablet" />
                    </coding>
                </unitOfPresentation>
                <manufacturer>
                    <reference value="Organization/PfizerServiceCompanyBV" />
                </manufacturer>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="AdministrableProductDefinition/ap1mgml" />
        <resource>
            <AdministrableProductDefinition>
                <id value="ap1mgml" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi" />
                </meta>
                <identifier>
                    <system value="https://www.who-umc.org/phpid" />
                    <value value="identifier" />
                </identifier>
                <status value="active" />
                <formOf>
                    <reference value="MedicinalProductDefinition/mp1mgml" />
                </formOf>
                <administrableDoseForm>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi/" />
                        <code value="100000073646" />
                        <display value="Oral solution" />
                    </coding>
                </administrableDoseForm>
                <unitOfPresentation>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="200000002111" />
                        <display value="Bottle" />
                    </coding>
                </unitOfPresentation>
                <producedFrom>
                    <reference value="ManufacturedItemDefinition/mid1mgml" />
                </producedFrom>
                <routeOfAdministration>
                    <code>
            <coding>
              <system value="https://spor.ema.europa.eu/rmswi" />
              <code value="100000073619" />
              <display value="Oral use" />
            </coding>
          </code>
                    <targetSpecies>
                        <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi" />
                <code value="100000109093" />
                <display value="Human" />
              </coding>
            </code>
                    </targetSpecies>
                </routeOfAdministration>
            </AdministrableProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="RegulatedAuthorization/authorization1mgml" />
        <resource>
            <RegulatedAuthorization>
                <id value="authorization1mgml" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="6ae5b5d9-7372-494c-874b-7dc67d386d2e" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/mp1mgml" />
                </subject>
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="220000000061" />
                        <display value="Marketing Authorisation" />
                    </coding>
                </type>
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" />
                        <code value="EU" />
                        <display value="European Union" />
                    </coding>
                </region>
                <status>
                    <coding>
                        <system value="http://hl7.org/fhir/publication-status" />
                        <code value="active" />
                        <display value="Active" />
                    </coding>
                </status>
                <statusDate value="2023-02-17T00:00:00Z" />
                <holder>
                    <reference value="Organization/PfizerEuropeMAEEIG" />
                </holder>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Organization/PfizerEuropeMAEEIG" />
        <resource>
            <Organization>
                <id value="PfizerEuropeMAEEIG" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://spor.ema.europa.eu/omswi" />
                    <value value="ORG-100011459" />
                </identifier>
                <active value="true" />
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="220000000034" />
                        <display value="Marketing authorisation holder" />
                    </coding>
                    <text value="Marketing authorisation holder" />
                </type>
                <name value="Pfizer Europe MA EEIG" />
                <contact>
                    <address>
                        <use value="work" />
                        <type value="physical" />
                        <text value="Pfizer Europe MA EEIG
                        Boulevard de la Plaine 17
                        1050 Bruxelles
                        Belgium" />
                        <line value="Boulevard de la Plaine 17" />
                        <city value="Bruxelles" />
                        <country value="BE" />
                    </address>
                </contact>
            </Organization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Organization/PfizerServiceCompanyBV" />
        <resource>
            <Organization>
                <id value="PfizerServiceCompanyBV" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://spor.ema.europa.eu/omswi" />
                    <value value="ORG-100005175" />
                </identifier>
                <active value="true" />
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="220000000033" />
                        <display value="Manufacturer" />
                    </coding>
                    <text value="Manufacturer" />
                </type>
                <name value="Pfizer Service Company BV" />
                <contact>
                    <address>
                        <use value="work" />
                        <type value="physical" />
                        <text value="Pfizer Service Company BV
                        Hoge Wei 10
                        1930 Zaventem
                        Belgium" />
                        <line value="Hoge Wei 10" />
                        <city value="Zaventem" />
                        <country value="BE" />
                    </address>
                </contact>
            </Organization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="PackagedProductDefinition/240mlbottle" />
        <resource>
            <PackagedProductDefinition>
                <id value="240mlbottle" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://spor.ema.europa.eu/pmswi" />
                    <value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab" />
                </identifier>
                <name value="white coloured HDPE 250 mL bottles containing 240 mL of solution." />
                <type>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000155527" />
                        <display value="Chemical Medicinal Product" />
                    </coding>
                </type>
                <packageFor>
                    <reference value="MedicinalProductDefinition/mp1mgml" />
                </packageFor>
                <status>
                    <coding>
                        <system value="http://hl7.org/fhir/publication-status" />
                        <code value="active" />
                        <display value="Active" />
                    </coding>
                </status>
                <statusDate value="2023-02-17T00:00:00Z" />
                <containedItemQuantity>
                    <value value="1" />
                    <system value="http://unitsofmeasure.org" />
                    <code value="1" />
                </containedItemQuantity>
                <description value="1 mg/mL oral solution is provided in white coloured HDPE 250 mL bottles containing 240 mL of
                solution. Each pack contains one HDPE bottle, one press-in bottle adapter, and one oral dosing syringe
                with 3.2 mL, 4 mL, and 5 mL graduations." />
                <manufacturer>
                    <reference value="Organization/PfizerServiceCompanyBV" />
                </manufacturer>
                <packaging>
                    <identifier>
                        <system value="https://spor.ema.europa.eu/pmswi" />
                        <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/rmswi" />
                            <code value="100000073497" />
                            <display value="Bottle" />
                        </coding>
                    </type>
                    <quantity value="1" />
                    <material>
                        <coding>
                            <system value="https://spor.ema.europa.eu/rmswi" />
                            <code value="200000003215" />
                            <display value="High Density PolyEthylene" />
                        </coding>
                    </material>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/mid1mgml" />
                            </reference>
                        </item>
                        <amount>
                            <value value="240" />
                            <unit value="mL" />
                            <system value="http://unitsofmeasure.org" />
                            <code value="mL" />
                        </amount>
                    </containedItem>
                </packaging>
                <packaging>
                    <identifier>
                        <system value="https://spor.ema.europa.eu/pmswi" />
                        <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/rmswi" />
                            <code value="100000073537" />
                            <display value="Oral syringe" />
                        </coding>
                    </type>
                    <quantity value="1" />
                    <material>
                        <coding>
                            <system value="https://spor.ema.europa.eu/rmswi" />
                            <code value="200000003215" />
                            <display value="High Density PolyEthylene" />
                        </coding>
                    </material>
                    <containedItem>
                        <amount>
                            <value value="3.2" />
                            <unit value="mL" />
                            <system value="http://unitsofmeasure.org" />
                            <code value="mL" />
                        </amount>
                    </containedItem>
                </packaging>
                <packaging>
                    <identifier>
                        <system value="https://spor.ema.europa.eu/pmswi" />
                        <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/rmswi" />
                            <code value="100000073537" />
                            <display value="Oral syringe" />
                        </coding>
                    </type>
                    <quantity value="1" />
                    <material>
                        <coding>
                            <system value="https://spor.ema.europa.eu/rmswi" />
                            <code value="200000003215" />
                            <display value="High Density PolyEthylene" />
                        </coding>
                    </material>
                    <containedItem>
                        <amount>
                            <value value="4" />
                            <unit value="mL" />
                            <system value="http://unitsofmeasure.org" />
                            <code value="mL" />
                        </amount>
                    </containedItem>
                </packaging>
                <packaging>
                    <identifier>
                        <system value="https://spor.ema.europa.eu/pmswi" />
                        <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/rmswi" />
                            <code value="100000073537" />
                            <display value="Oral syringe" />
                        </coding>
                    </type>
                    <quantity value="1" />
                    <material>
                        <coding>
                            <system value="https://spor.ema.europa.eu/rmswi" />
                            <code value="200000003215" />
                            <display value="High Density PolyEthylene" />
                        </coding>
                    </material>
                    <containedItem>
                        <amount>
                            <value value="5" />
                            <unit value="mL" />
                            <system value="http://unitsofmeasure.org" />
                            <code value="mL" />
                        </amount>
                    </containedItem>
                </packaging>
                <packaging>
                    <identifier>
                        <system value="https://spor.ema.europa.eu/pmswi" />
                        <value value="5913fadd-6172-4282-ad02-19ab9d063b66" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="https://spor.ema.europa.eu/rmswi" />
                            <code value="100000073557" />
                            <display value="Stopper" />
                        </coding>
                        <text value="one press-in bottle adapter" />
                    </type>
                    <quantity value="1" />
                    <material>
                        <coding>
                            <system value="https://spor.ema.europa.eu/rmswi" />
                            <code value="200000003215" />
                            <display value="High Density PolyEthylene" />
                        </coding>
                    </material>
                </packaging>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="MedicinalProductDefinition/mp1mgml" />
        <resource>
            <MedicinalProductDefinition>
                <id value="mp1mgml" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi" />
                </meta>
                <identifier>
                    <system value="http://ema.europa.eu/fhir/epiDocument" />
                    <value value="471bb15-7f52-4fcd-b615-8674ce6eb91e" />
                </identifier>
                <type>
                    <coding>
                        <system value="http://hl7.org/fhir/medicinal-product-type" />
                        <code value="MedicinalProduct" />
                        <display value="Medicinal Product" />
                    </coding>
                </type>
                <domain>
                    <coding>
                        <system value="http://hl7.org/fhir/medicinal-product-domain" />
                        <code value="Human" />
                        <display value="Human use" />
                    </coding>
                </domain>
                <status>
                    <coding>
                        <system value="http://hl7.org/fhir/publication-status" />
                        <code value="active" />
                        <display value="active" />
                    </coding>
                </status>
                <legalStatusOfSupply>
                    <coding>
                        <system value="https://spor.ema.europa.eu/rmswi" />
                        <code value="100000072084" />
                        <display value="Medicinal product subject to medical prescription" />
                    </coding>
                </legalStatusOfSupply>
                <name>
                    <productName value="XELJANZ® (tofacitinib) 1 mg/ml oral solution" />
                    <part>
                        <part value="XELJANZ" />
                        <type>
                            <coding>
                                <system value="https://spor.ema.europa.eu/lists/220000000000" />
                                <code value="220000000002" />
                                <display value="Invented name part" />
                            </coding>
                        </type>
                    </part>
                    <part>
                        <part value="Tofacitinib citrate" />
                        <type>
                            <coding>
                                <system value="https://spor.ema.europa.eu/lists/220000000000" />
                                <code value="220000000003" />
                                <display value="Scientific name part" />
                            </coding>
                        </type>
                    </part>
                    <part>
                        <part value="1 mg/ml" />
                        <type>
                            <coding>
                                <system value="https://spor.ema.europa.eu/lists/220000000000" />
                                <code value="220000000004" />
                                <display value="" />
                            </coding>
                        </type>
                    </part>
                    <part>
                        <part value="Oral solution" />
                        <type>
                            <coding>
                                <system value="https://spor.ema.europa.eu/lists/220000000000" />
                                <code value="220000000005" />
                                <display value="Pharmaceutical dose form part" />
                            </coding>
                        </type>
                    </part>
                    <usage>
                        <country>
                            <coding>
                                <system value="urn:iso:std:iso:3166" />
                                <code value="EU" />
                                <display value="European Union" />
                            </coding>
                        </country>
                        <jurisdiction>
                            <coding>
                                <system value="urn:iso:std:iso:3166" />
                                <code value="EU" />
                                <display value="European Union" />
                            </coding>
                        </jurisdiction>
                        <language>
                            <coding>
                                <system value="urn:ietf:bcp:47" />
                                <code value="en" />
                                <display value="English" />
                            </coding>
                        </language>
                    </usage>
                </name>
            </MedicinalProductDefinition>
        </resource>
    </entry>
</Bundle>